文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

幽门螺杆菌与胃上皮内瘤变及早期胃癌中程序性死亡蛋白-1及其配体表达的关系

Relationship between Helicobacter pylori and expression of programmed death-1 and its ligand in gastric intraepithelial neoplasia and early-stage gastric cancer.

作者信息

Shen Bo, Qian Aihua, Lao Wenji, Li Weiguang, Chen Xi, Zhang Benyan, Wang Huafeng, Yuan Fei, Sun Yunwei

机构信息

Department of Gastroenterology of Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, People's Republic of China.

Department of Pathology of Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, People's Republic of China.

出版信息

Cancer Manag Res. 2019 May 2;11:3909-3919. doi: 10.2147/CMAR.S203035. eCollection 2019.


DOI:10.2147/CMAR.S203035
PMID:31190978
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6525832/
Abstract

Many studies have shown that programmed cell death protein 1 (PD-1) and its ligand, PD-L1, are expressed in advanced gastric cancer. Furthermore, detection of these proteins is associated with infiltrating CD8+ T-cells, indicating that an adaptive immune resistance mechanism occurs in advanced gastric cancer. However, PD-L1 and PD-1 expression in gastric intraepithelial neoplasia and early-stage gastric cancer (EGC) has yet to be elucidated. Fifty-four resections of low-grade intraepithelial neoplasia (LGIN), high-grade intraepithelial neoplasia (HGIN), and EGC were stained by immunohistochemistry for PD-1, PD-L1, and CD8. CD8+ T-cell densities both within tumors and in the tumor-stromal interface were analyzed. Flow cytometry (FACS) was used to analyze the PD-1 expression in tumor tissues and peripheral blood mononuclear cells. Furthermore, the relationship between Helicobacter pylori (Hp) infection and PD-1 and PD-L1 was also evaluated. We demonstrated that PD-L1 expression was significantly increased in HGIN and EGC compared with LGIN, and both PD-1 and PD-L1 showed similar expression patterns, being mainly detected in infiltrating immune cells. FACS also showed that PD-1 was expressed on both CD4+ and CD8+ T-cells. However, no difference was found in CD8+ T-cell infiltration between LGIN and HGIN+EGC, and this was not not found to be associated with PD-L1 or PD-1 expression. However, Hp infection was significantly associated with expression of PD-L1 and PD-1. The PD-1/PD-L1 checkpoint is involved in intraepithelial neoplasia and EGC, but an adaptive immune resistance mechanism does not occur. Expression of PD-1/PD-L1 is also associated with Hp infection, and so Hp infection may be an important initiating factor. This study was approved by the Institutional Review Board of Ruijin Hospital and written informed consent was obtained from all patients.

摘要

许多研究表明,程序性细胞死亡蛋白1(PD - 1)及其配体PD - L1在进展期胃癌中表达。此外,这些蛋白的检测与浸润性CD8 + T细胞相关,表明进展期胃癌中存在适应性免疫抵抗机制。然而,胃上皮内瘤变和早期胃癌(EGC)中PD - L1和PD - 1的表达情况尚未阐明。对54例低级别上皮内瘤变(LGIN)、高级别上皮内瘤变(HGIN)和EGC切除标本进行免疫组织化学染色,检测PD - 1、PD - L1和CD8。分析肿瘤内及肿瘤-基质界面处CD8 + T细胞密度。采用流式细胞术(FACS)分析肿瘤组织和外周血单个核细胞中PD - 1的表达。此外,还评估了幽门螺杆菌(Hp)感染与PD - 1和PD - L1之间的关系。我们发现,与LGIN相比,HGIN和EGC中PD - L1表达显著增加,且PD - 1和PD - L1表现出相似的表达模式,主要在浸润性免疫细胞中检测到。FACS还显示PD - 1在CD4 +和CD8 + T细胞上均有表达。然而,LGIN与HGIN + EGC之间CD8 + T细胞浸润无差异,且未发现其与PD - L1或PD - 1表达相关。但是,Hp感染与PD - L1和PD - 1的表达显著相关。PD - 1/PD - L1免疫检查点参与上皮内瘤变和EGC,但不存在适应性免疫抵抗机制。PD - 1/PD - L1的表达也与Hp感染相关,因此Hp感染可能是一个重要的起始因素。本研究经瑞金医院伦理委员会批准,所有患者均签署书面知情同意书。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dec6/6525832/cc5e3145bd58/CMAR-11-3909-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dec6/6525832/5439f51a6e5e/CMAR-11-3909-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dec6/6525832/9cab7587dbfe/CMAR-11-3909-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dec6/6525832/6e056aa020ac/CMAR-11-3909-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dec6/6525832/02e69c8a78dc/CMAR-11-3909-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dec6/6525832/080976036276/CMAR-11-3909-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dec6/6525832/cc5e3145bd58/CMAR-11-3909-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dec6/6525832/5439f51a6e5e/CMAR-11-3909-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dec6/6525832/9cab7587dbfe/CMAR-11-3909-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dec6/6525832/6e056aa020ac/CMAR-11-3909-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dec6/6525832/02e69c8a78dc/CMAR-11-3909-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dec6/6525832/080976036276/CMAR-11-3909-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dec6/6525832/cc5e3145bd58/CMAR-11-3909-g0006.jpg

相似文献

[1]
Relationship between Helicobacter pylori and expression of programmed death-1 and its ligand in gastric intraepithelial neoplasia and early-stage gastric cancer.

Cancer Manag Res. 2019-5-2

[2]
Differential gene expression profiling of gastric intraepithelial neoplasia and early-stage adenocarcinoma.

World J Gastroenterol. 2014-12-21

[3]
Expression of Oncostatin M in Early Gastric Cancer and Precancerous Lesions.

Gastroenterol Res Pract. 2019-12-1

[4]
Dissecting expression profiles of gastric precancerous lesions and early gastric cancer to explore crucial molecules in intestinal-type gastric cancer tumorigenesis.

J Pathol. 2020-5-27

[5]
The crosstalk between H. pylori virulence factors and the PD1:PD-L1 immune checkpoint inhibitors in progression to gastric cancer.

Immunol Lett. 2021-11

[6]
Patterns of PD-L1 expression and CD8 T cell infiltration in gastric adenocarcinomas and associated immune stroma.

Gut. 2017-5

[7]
Quantitative Analysis on Molecular Characteristics Evolution of Gastric Cancer Progression and Prognosis.

Adv Biol (Weinh). 2023-10

[8]
Health-Related Quality of Life and Utility Scores of Posttreatment Patients with Gastric Cancer at Different Pathological Stages: A Cross-Sectional Study.

J Oncol. 2022-4-23

[9]
Expression patterns of programmed death-1 and programmed death-1 ligand-1 on T cells in gastric cancer.

Oncol Lett. 2019-9

[10]
Establishment and Evaluation of a Risk Prediction Model for Pathological Escalation of Gastric Low-Grade Intraepithelial Neoplasia.

J Vis Exp. 2024-2-16

引用本文的文献

[1]
Myeloid-derived suppressor cells modulation in the context of tumor microenvironment for gastric cancer.

Clin Transl Oncol. 2025-6-24

[2]
Single-cell dissection of prognostic architecture and immunotherap response in infection-associated gastric cancer.

Elife. 2025-6-17

[3]
Transcriptional profiling reveals -associated genes induced inflammatory cell infiltration and chemoresistance in gastric cancer.

Front Immunol. 2025-5-30

[4]
infection negatively affects response of gastric cancer to immunotherapy.

Ann Gastroenterol. 2025

[5]
Relationship between infection and programmed death-ligand 1 in gastric cancer: A meta-analysis.

World J Clin Oncol. 2025-4-24

[6]
Recent advances in the mechanisms of PD-L1 expression in gastric cancer: a review.

Biol Res. 2025-3-17

[7]
Helicobacter pylori CagA promotes immune evasion of gastric cancer by upregulating PD-L1 level in exosomes.

iScience. 2023-11-9

[8]
Identification of as a Gastric Fungus Associated with PD-L1 Expression and Overall Survival of Patients with Gastric Cancer.

J Immunol Res. 2022

[9]
Advances in molecular biomarkers research and clinical application progress for gastric cancer immunotherapy.

Biomark Res. 2022-8-30

[10]
Effects of on tumor microenvironment and immunotherapy responses.

Front Immunol. 2022

本文引用的文献

[1]
.

Porto Biomed J. 2016

[2]
Immune environment in serrated lesions of the colon: intraepithelial lymphocyte density, PD-1, and PD-L1 expression correlate with serrated neoplasia pathway progression.

Hum Pathol. 2018-8-31

[3]
Analysis of PD1, PDL1, PDL2 expression and T cells infiltration in 1014 gastric cancer patients.

Oncoimmunology. 2017-12-21

[4]
Genetic host factors in Helicobacter pylori-induced carcinogenesis: Emerging new paradigms.

Biochim Biophys Acta Rev Cancer. 2017-11-24

[5]
PD-1/PD-L1 and immunotherapy for pancreatic cancer.

Cancer Lett. 2017-8-18

[6]
Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade.

Science. 2017-7-28

[7]
Gastric Cancer as Preventable Disease.

Clin Gastroenterol Hepatol. 2017-5-19

[8]
Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report.

Gut. 2016-10-5

[9]
Pembrolizumab for patients with PD-L1-positive advanced gastric cancer (KEYNOTE-012): a multicentre, open-label, phase 1b trial.

Lancet Oncol. 2016-5-3

[10]
Patterns of PD-L1 expression and CD8 T cell infiltration in gastric adenocarcinomas and associated immune stroma.

Gut. 2017-5

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索